Discount Agreements for Pharmaceuticals 2024-07
The Techniker Krankenkasse is entering into discount agreements for various pharmaceuticals through an open-house procedure. The goal is to achieve cost reductions on interchangeable finished medicinal products, with contract durations of up to 24 months.
CONTRACTING AUTHORITY
CLASSIFICATION
Procedure Type
Open Procedure
Contract Type
Supplies
Main CPV
33600000, Pharmaceutical products.
LOTS (27)
Abirateron (223,16 mg N2)
Abirateron (892,64 mg 28 St.)
Baclofen (parenterale DRF)
Beclometason dipropionat (nasale DRF, Rx)
Beclometason dipropionat/Formoterol (DOS)
Calciumdiacetat (ausgenommen 500 mg N2, 700 mg)
Captopril/Hydrochlorothiazid (ausgenommen 25mg/25mg N2)
Dexamethason/Gentamicin (AUS)
Dimenhydrinat (KSU, SUP)
Dimenhydrinat (TAB, UTA)
Eisen(II)-Sulfat (ausgenommen RET)
Eisen(II)-Sulfat (RET)
Enoxaparin natrium (100 mg N2)
Fampridin (ausgenommen N1, N2)
Goserelin
Latanoprost (EDP)
Levodropropizin (ausgenommen FTA, TRO)
Melatonin (retardierte DRF, ausgenommen 2 mg)
Methylprednisolon (PLH)
Nifedipin (ausgenommen WKA, TEI)
Stiripentol (HKP)
Stiripentol (PSE)
Tapentadol (RET, N1 (24 St.), N2 (54 St.))
Tinzaparin natrium (ausgenommen DFL, 6 St., N1)
Tinzaparin natrium (ausgenommen DFL; N1 3.500 I.E. + 4.500 I.E.)
Tinzaparin natrium (ausgenommen DFL; N1 ausgenommen 3.500 I.E. + 4.500 I.E.)
Tolvaptan (ATC: C03XA01; 7,5 mg)
ADDITIONAL DETAILS
Legal Basis
32014L0024
DEADLINES & TIMELINE
Submission Deadline
744 days remaining(LOT-0001)
Published